Clinical trials
Completed Non-Muscle Invasive Bladder Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
77 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2003 | 2 |
| 2004 | 2 |
| 2005 | 1 |
| 2006 | 2 |
| 2008 | 3 |
| 2009 | 3 |
| 2011 | 3 |
| 2012 | 3 |
| 2013 | 3 |
| 2014 | 5 |
| 2015 | 6 |
| 2016 | 5 |
| 2017 | 1 |
| 2018 | 6 |
| 2019 | 4 |
| 2020 | 8 |
| 2021 | 5 |
| 2022 | 5 |
| 2023 | 4 |
| 2024 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 77 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| UroGen Pharma Ltd. | 7 |
| University of Rome Tor Vergata | 4 |
| Eli Lilly and Company | 2 |
| Halozyme Therapeutics | 2 |
| Mansoura University | 2 |
| Protara Therapeutics | 2 |
| A.O.U. Città della Salute e della Scienza | 1 |
| Aadi Bioscience, Inc. | 1 |
| Abnoba Gmbh | 1 |
| Ain Shams University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Non-Muscle Invasive Bladder Neoplasms | 77 |
| Urinary Bladder Neoplasms | 46 |
| Recurrence | 8 |
| Carcinoma, Transitional Cell | 7 |
| Disease Progression | 5 |
| Urologic Neoplasms | 5 |
| Carcinoma in Situ | 4 |
| Urinary Bladder Diseases | 4 |
| Urologic Diseases | 4 |
| Neoplasms | 3 |
Trials
Showing 76 to 77 of 77. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.